Area of research
Radiology, Nuclear Medicine and Imaging · Epidemiology
Research interest
Research interests include Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications, Neuroendocrine Tumor Research Advances, and Radiomics and Machine Learning in Medical Imaging.
Synthesis and in vitro characterization of [198Au]Auranofin
Long circulating XTEN864-HGV-Apoptin fusion protein for selective cancer therapy.
Effects of isoflurane anaesthesia depth and duration on renal function measured with [<sup>99m</sup>Tc]Tc-mercaptoacetyltriglycine SPECT in mice.
Detection of recurrent high-grade glioma using microstructure characteristics of distinct metabolic compartments in a multimodal and integrative 18F-FET PET/fast-DKI approach.
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model.
Predictive factors for the outcome of radioiodine therapy in patients with benign thyroid diseases.
ChatGPT: Can You Prepare My Patients for [<sup>18</sup>F]FDG PET/CT and Explain My Reports?
[<sup>177</sup>Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement
[<sup>177</sup>Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement.
Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for 68Ga, 177Lu and 198Au
Optimization of 177Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET.
Detection of recurrent high-grade glioma using microstructure characteristics of distinct metabolic compartments in a multimodal and integrative 18F-FET PET/fast-DKI approach
Optimization of <sup>177</sup>Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application.
Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for <sup>68</sup>Ga, <sup>177</sup>Lu and <sup>198</sup>Au.
Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera®
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model
Unified Bayesian network for uncertainty quantification of physiological parameters in dynamic contrast enhanced (DCE) MRI of the liver.
Evaluation of the <sup>177m</sup>Lu-concentration in in-house produced <sup>177</sup>Lu-radiopharmaceuticals and commercially available Lutathera<sup>®</sup>.
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors.
Abstracts der JA-PED 2023
[Is there an unmet need to establish a young talent section "Young DGN" within the German Society of Nuclear Medicine (DGN)? - Results of a 2021/2022 web-based survey among German Nuclear Medicine professionals].
<sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism.
[68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma
Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT
[<sup>68</sup>Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [<sup>177</sup>Lu]Lu-PSMA therapy in relapsing high-grade glioma.
Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization.
Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT.
Dynamic <sup>18</sup>F-FET PET/CT to differentiate recurrent primary brain tumor and brain metastases from radiation necrosis after single-session robotic radiosurgery.
[Radioiodine testing in clinical routine: Status in Germany 2021].